Research Area
Revealing how psilocybin changes brain activity, connectivity, and neural patterns through advanced imaging technology
Brain imaging studies using fMRI, PET scans, and other technologies have revolutionized our understanding of how psilocybin works. These studies allow researchers to observe the brain in real-time during psilocybin experiences, revealing dramatic changes in neural activity and connectivity. Perhaps the most significant finding is psilocybin's effect on the Default Mode Network (DMN)—a brain network associated with self-referential thinking and the ego. Psilocybin reduces DMN activity while increasing connectivity between brain regions that don't normally communicate, potentially explaining both the subjective experience of ego dissolution and the lasting therapeutic benefits.
Psilocybin significantly reduces activity in the Default Mode Network, a brain network associated with self-referential thinking, rumination, and the sense of ego. This correlates with reports of ego dissolution and mystical experiences.
Under psilocybin, brain regions that don't normally communicate begin to connect, creating a more 'integrated' brain state. This hyperconnectivity may underlie the novel insights and perspectives reported during experiences.
Neuroimaging work (Imperial College London, 2012 onward) suggests psilocybin may promote neuroplasticity—the brain's ability to form new connections—potentially explaining why single experiences can produce lasting changes in mood, personality, and behavior.
Key Finding
Psilocybin decreased activity in hub regions of the brain, particularly the medial prefrontal cortex and posterior cingulate cortex, key nodes of the Default Mode Network.
Key Finding
Psilocybin dramatically increased functional connectivity between brain regions, creating a more interconnected brain state compared to placebo.
Key Finding
Increased amygdala responses to emotional faces post-treatment correlated with clinical improvement, suggesting psilocybin may work by increasing emotional responsiveness.
Brain imaging studies help explain why psilocybin experiences feel so profound and why they can produce lasting changes. The Default Mode Network finding is particularly important—this network is overactive in depression, where it's associated with rumination and negative self-focus. By temporarily disrupting the DMN, psilocybin may break the cycle of negative thinking and allow new perspectives to emerge. The increased connectivity between brain regions may explain why people often describe psilocybin experiences as providing new insights or seeing things from a different angle. It's as if the brain's usual boundaries are temporarily dissolved, allowing for novel connections and associations. The neuroplasticity findings suggest these changes aren't just temporary—psilocybin may actually help the brain rewire itself, which could explain why benefits persist long after the drug has left the system.
Rigorous controlled studies testing psilocybin's safety, efficacy, and therapeutic potential in human participants
View ResearchGroundbreaking research showing psilocybin's remarkable potential for treating depression, including treatment-resistant cases
View ResearchEmerging research exploring psilocybin's potential for treating post-traumatic stress disorder and trauma-related conditions
View ResearchThe research presented on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. The studies cited were conducted in controlled clinical settings with extensive screening, preparation, and professional support—results may not be replicable outside these conditions. Psilocybin remains a Schedule I controlled substance under federal law in the United States and is illegal in many jurisdictions worldwide. Always consult a qualified healthcare provider before making decisions about your health.